Experimental use of this peptide assists in clarifying the structure-activity relationships essential for the development of next-generation neuroactive peptides, providing insights into the design of molecules with improved specificity and efficacy
But after the 2 months it was good
Evidence snapshot: The strongest human evidence comes from a 2-year randomized controlled trial in 65 healthy older adults (Nass et al., 2008, Annals of Internal Medicine) showing sustained GH/IGF-1 increases and preserved fat-free mass, plus an earlier short-term human polysomnography study on sleep (Copinschi et al., 1997, Neuroendocrinology, PMID 9349662)
Instead, start with a larger injection volume of 3mL or more
Stability is the second reason researchers favour this peptide
Endotoxin testing below safe thresholds protects against bacterial contamination